FDA Adverse Event Injury Summary report: N

UNKNOWN SOLITAIRE

MDR report key: 13502533 · Received February 9, 2022

Report

Report Number
2029214-2022-00195
Event Type
Injury
Date Received
February 9, 2022
Date of Event
June 29, 2021
Report Date
February 9, 2022
Manufacturer
MICRO THERAPEUTICS, INC. DBA EV3
Product Code
NRY
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
CH
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

LI Z, ZHANG H, HAN J, ET AL. TIME COURSE AND CLINICAL RELEVANCE OF NEUROLOGICAL DETERIORATION AFTER ENDOVASCULAR RECANALIZATION THERAPY FOR ANTERIOR CIRCULATION LARGE VESSEL OCCLUSION STROKE. FRONTIERS IN AGING NEUROSCIENCE. 2021;13:651614. DOI:10.3389/FNAGI.2021.651614. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.

Description of Event or Problem · 0

LI Z, ZHANG H, HAN J, ET AL. TIME COURSE AND CLINICAL RELEVANCE OF NEUROLOGICAL DETERIORATION AFTER ENDOVASCULAR RECANALIZATION THERAPY FOR ANTERIOR CIRCULATION LARGE VESSEL OCCLUSION STROKE. FRONTIERS IN AGING NEUROSCIENCE. 2021;13:651614. DOI:10.3389/FNAGI.2021.651614. MEDTRONIC LITERATURE REVIEW FOUND A REPORT OF PATIENT COMPLICATIONS IN ASSOCIATION WITH A SOLITAIRE DEVICE. THE PURPOSE OF THIS ARTICLE WAS TO INVESTIGATE THE TIME COURSE AND CLINICAL RELEVANCE OF NEUROLOGICAL DETERIORATION (ND) AFTER ENDOVASCULAR RECANALIZATION THERAPY (EVT). THERE WERE 343 PATIENTS INCLUDED IN THE STUDY (155 FEMALE, MEAN AGE 68.5 YEARS). THE ARTICLE DOES NOT STATE ANY TECHNICAL ISSUES DURING USE OF THE SOLITAIRE. THE FOLLOWING INTRA- OR POST-PROCEDURAL OUTCOMES WERE NOTED: -129 PATIENTS EXPERIENCED NEUROLOGICAL DETERIORATION, WHICH WAS DEFINED AS AN INCREASE OF FOUR POINTS OR MORE IN THE NIHSS SCORE COMPARED TO THE BEST NEUROLOGICAL STATUS DURING HOSPITALIZATION. OF THESE, 94 WERE TREATED WITH A SOLITAIRE FIRST DURING EVT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
895657 UNKNOWN SOLITAIRE CATHETER, THROMBUS RETRIEVER NRY MICRO THERAPEUTICS, INC. DBA EV3 UNK-NV-SOLITAIRE UNKNOWN

Patients

Seq Age Sex Outcome Treatment
1 68 YR Male Other